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Abstract
BACKGROUND 
Multiple sites of metastasis and desmoplastic reactions in the stroma are key 
features of human pancreatic cancer (PC). There are currently no simple and 
reliable animal models that can mimic these features for accurate disease 
modeling.
AIM 
To create a new xenograft animal model that can faithfully recapitulate the 
features of human PC.
METHODS 
Interleukin 2 receptor subunit gamma (IL2RG) gene knockout Syrian hamster was 
created and characterized. A panel of human PC cell lines were transplanted into 
IL2RG knockout Syrian hamsters and severe immune-deficient mice 
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subcutaneously or orthotopically. Tumor growth, local invasion, remote organ 
metastasis, histopathology, and molecular alterations of tumor cells and stroma 
were compared over time.
RESULTS 
The Syrian hamster with IL2RG gene knockout (named ZZU001) demonstrated an 
immune-deficient phenotype and function. ZZU001 hamsters faithfully 
recapitulated most features of human PC, in particular, they developed metastasis 
at multiple sites. PC tissues derived from ZZU001 hamsters displayed 
desmoplastic reactions in the stroma and epithelial to mesenchymal transition 
phenotypes, whereas PC tissues derived from immune-deficient mice did not 
present such features.
CONCLUSION 
ZZU001 hamsters engrafted with human PC cells are a superior animal model 
compared to immune-deficient mice. ZZU001 hamsters can be a valuable animal 
model for better understanding the molecular mechanism of tumorigenesis and 
metastasis and the evaluation of new drugs targeting human PC.
Key words: Pancreatic cancer; Xenotrans plantation; Syrian hamster; IL-2 receptor gamma 
chain gene; Metastasis; Animal model
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Core tip: Xenograft cell transplantation into immune-deficient mice has become the gold 
standard for assessing tumor progression and efficacy of cancer drugs. However, 
xenografting human pancreatic cancer (PC) models in nude mice rarely results in 
development of metastasis and thus does not accurately reflect tumor progression as seen 
in the human disease. Here, we created a new immune-deficient Syrian hamster with 
interleukin 2 receptor subunit gamma (IL2RG) gene knockout and demonstrated that the 
IL2RG-/- Syrian hamster is a promising animal model that can faithfully recapitulate most 
features of human PC, notably multiple sites of metastasis. Furthermore, this model can 
present other key features of human PC, such as stromal reaction and the communication 
between stromal cells and PC cells.
Citation: Miao JX, Wang JY, Li HZ, Guo HR, Dunmall LSC, Zhang ZX, Cheng ZG, Gao DL, 
Dong JZ, Wang ZD, Wang YH. Promising xenograft animal model recapitulating the features 




Pancreatic cancer (PC) is one of the most deadly human diseases, with a 5-year 
survival rate of less than 7%. It is predicted to be the second leading cause of cancer-
associated mortality within the next decade in developed countries[1]. Even when 
primary cancer can be removed by radical surgery, the recurrence rate of PC is as high 
as 85%[2,3]. Multiple-sites of metastasis from PC remains a significant hurdle in treating 
this disease. Thus, reliable animal models that can mimic the clinical features of PC are 
needed for better understanding the molecular mechanisms of tumorigenesis, 
development of practical approaches for early diagnosis, and evaluation of novel 
therapeutic agents.
In preclinical studies, there have been several models developed for human PC 
research, such as human PC cell lines, cell line-based xenografts, patient-derived 
tumor xenografts, transgenic mice models, as well as recently developed pancreatic 
ductal organoids, three-dimensional culture systems, and organoid-based 
xenografts[4]. Among these models, xenografting of human tumor cells into immune-
deficient mice has become the gold standard for assessing tumor progression and the 
preclinical efficacy of cancer drugs. However, subcutaneous xenograft PC tumor 
models in nude mice rarely develop metastasis[5]. The orthotopic model of human PC 
Miao JX et al. Syrian hamster as pancreatic cancer models
WJG https://www.wjgnet.com 4804 August 28, 2020 Volume 26 Issue 32
Published online: August 28, 2020
P-Reviewer: Sun XT, Wang XB, 
Zhang XB 
S-Editor: Zhang L 
L-Editor: Filipodia 
P-Editor: Zhang YL
in nude mice provides a better way to evaluate tumor growth, but metastasis to the 
lung or/and other organs occurs rarely from most human PC cell lines tested[6,7]. 
Furthermore, it has been shown that cell-line based xenografts in immune-deficient 
mice could not consistently predict therapeutic response of human PC[8-11]. The lack of 
predictive drug responsiveness using xenograft models is likely due to multiple 
factors[4]. The major reason is that xenografts of human tumors grow primarily in 
immune-deficient mice as homogenous masses of tumor cells with limited stromal 
infiltration. This may be particularly relevant for PC, since PC tumors are 
predominantly comprised of a stromal compartment consisting of an acellular 
extracellular matrix and a variety of non-neoplastic cell types, such as cancer-
associated fibroblasts, immune cells, and vascular cells[12]. To overcome these 
challenges, more robust animal models are needed.
Accumulating evidence demonstrates that Syrian hamsters (Mesocricetus auratus) 
have advantages as models for various diseases due to the high similarities in 
anatomy, physiology, and pathology between Syrian hamsters and humans[13,14]. The 
Syrian hamster is the only rodent species that develops PC in an almost identical 
manner to the respective human disease regarding such features as clinical symptoms, 
tumor morphology, tumor biology, metabolic abnormality, and molecular genetic 
alterations[15]. In addition, we recently found that human interleukin (IL)-12 is effective 
in stimulating both human and hamster peripheral blood mononuclear cells. Human 
IL-12 effectively stimulates interferon-gamma and tumor necrosis factor-alpha 
expression in activated hamster splenocytes ex vivo and demonstrates toxicity in vivo in 
Syrian hamsters bearing PC[16]. However, human IL-12 does not function in mouse at 
all. Similarly, human granulocyte-macrophage colony-stimulating factor functions on 
hamster cells but not on mouse cells[17]. These observations suggest that human tumor 
cells may be able to communicate with the host cells of Syrian hamster through human 
tumor cell secreting molecules that function on Syrian hamster cells. We reasoned that 
immunocompromised Syrian hamsters might be the most appropriate hosts for human 
cancer xenografting to model the features of human PC. Recently, we made a technical 
breakthrough in establishing efficient gene targeting techniques in the Syrian 
hamster[18]. Here, we report the creation and characterization of an IL-2 receptor 
subunit gamma (IL2RG) gene knockout Syrian hamster model (named ZZU001) and its 
use as a host for human PC cell xenotransplantation. ZZU001 represents a convenient, 
cost-effective, and reliable model for recapitulating the progression and multiple-sites 
metastasis of human PC.
MATERIALS AND METHODS
Animals and ethics statement
Syrian hamsters (4- to 5-wk-old, 80 g in weight) were purchased from Beijing Vital 
River Laboratory Animal Technology Co. (Beijing, China). B-NDG (NOD-Prkdcscid 
IL2rgtm1/Bcgen mice deficient in mature T lymphocytes, B lymphocytes, and natural 
killer cells) mice (4- to 5-wk-old, male, 20 g in weight) were purchased from Beijing 
Biocytogen Co., Ltd. (Beijing, China). The animals were maintained under specific 
pathogen-free, 14 h light/10 h dark cycle (room temperature 23 ± 0.5°C, humidity 40%-
60%) conditions, and the animals had free access to irradiated chow and water. To 
ameliorate the suffering of animals observed throughout experimental studies, 
animals were euthanized by CO2 inhalation. All surgery was performed under 
intraperitoneal injection of Avertin (Sigma-Aldrich, St Louis, MO, United States) 
anesthesia, and all efforts were made to minimize animal suffering. Avertin Stock 
solution was prepared as follows: 25 g avertin (2, 2, 2-Tribromoethanol) and 15.5 mL 
tert-Amyl Alcohol (2-methyl-2-butanol) mixed approximately 12 h in a dark bottle at 
room temperature. Working solution was prepared as follows: 0.5 mL Avertin stock 
and 39.5 mL 0.9% saline (NaCl) mixed in dark container, filter sterilized, and stored at 
4°C. All animal care and experiments were approved by the Ethical Committee of the 
Zhengzhou University and were in accordance with the Provision and General 
Recommendation of Chinese Experimental Animals Administration Legislation.
Cell lines and adenovirus
All human pancreatic cell lines listed in Table 1 and A549 cell line were purchased 
from American Type Culture Collection (ATCC, Manassas, VA, United States). All the 
cell lines had been short tandem repeat genotyped and confirmed identical to the 
published deoxyribonucleic acid (DNA) profiles of the American Type Culture 
Collection. All cells were grown in Dulbecco’s modified Eagle’s medium (Gibco, 
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Table 1 Sites and frequency [n/n (%)] of distant metastasis and local tumor infiltration of MIA-PaCa-2 cells
MIAPaCa-2 (SC) MIAPaCa-2 (OrT)
B-NDG ZZU001 B-NDG ZZU001
Distant metastasis
Liver - - 3/5 (60) 5/5 (100)
Lung - 5/5 (100) - 5/5 (100)
Retroperitoneum - - 3/5 (60) 5/5 (100)
Mesentery - - 3/5 (60) 5/5 (100)
Diaphragm - - 2/5 (40) 2/5 (40)
Spleen - - 2/5 (40) -
Stomach - - - 1/5 (20)
Kidney - 2/5 (40) - 5/5 (100)
Adrenal gland - 1/5 (20) - 2/5 (40)
Local infiltration
Spleen - - 3/5(60) 4/5 (80)
Stomach - - 1/5 (20) 3/5 (60)
Liver (hilus) - - 3/5 (60) 5/5 (100)
Kidney (hilus) - - - 1/5 (20)
Retroperitoneum - - 3/5 (60) 5/5 (100)
Bowel - - 3/5 (60) 5/5 (100)
Mesentery (adjacent to pancreas) - 4/5 (80) 5/5 (100)
Signs of tumor burden
Ascites - - 3/5 (60) 3/5 (60)
Jaundice - - 2/5 (40) 3/5 (60)
Ileus - - - 2/5 (40)
Cachexia - - 1/5 (20) 3/5 (60)
OrT: Orthotopic; SC: Subcutaneous.
Grand Island, NY, United States) supplemented with 10% fetal bovine serum (PAN, 
Germany), 50 μg/mL streptomycin, and 50 μg/mL penicillin (Sigma-Aldrich). Cells 
were maintained at 37°C and 5% CO2. Human Adenovirus type 5 (Ad5) was made and 
titrated as previously described[14].
Generation of IL2RG knockout (ZZU001) Syrian hamsters by CRISPR/Cas9
Single-guide ribonucleic acid (sgRNA) design, synthesis, embryo manipulation, and 
embryo transfer were performed for establishment of IL2RG-/- Syrian hamster, as 
described previously[18]. In brief, sgRNA was designed to target a site-specific sequence 
within the first exon of IL2RG gene (NW_004801714.1). Microinjection was performed 
under red light, and HECM-9 medium covered by mineral oil was used as injection 
medium. For cytoplasmic injection, both Cas9 mRNA (100 ng/μL) and sgRNA (50 
ng/μL) were co-injected into the cytoplasm of the fertilized eggs. The injected embryos 
were cultured in HECM-9 medium covered by mineral oil at 37.5˚C under 10% CO2, 
5% O2, and 85% N2 for 0.5 h before use. Viable embryos after injection were transferred 
to each oviduct (15 embryos per oviduct) of pseudo-pregnant females. Genotyping 
analysis of pups produced from microinjected embryos was performed by Sanger 
sequence with genomic DNA isolated from toes collected from 2-wk-old pups. 
Genomic regions flanking the CRISPR targeted sites were amplified by polymerase 
chain reaction (PCR) using primers; Forward: GAGAGTGGTTCAGGGTTCTGACA, 
Reverse: TGGGCTGGAGCTCAGAACTG. The PCR products were directly sequenced. 
Potential off-target effect was analyzed based on the rule that sequences matching the 
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final 12 nt of the target sequence and protospacer adjacent motif sequence might cause 
the off-target effect[19]. The off-target fragments were amplified from the founder's 
genomic DNA and identified by Sanger sequence. The primer sequences are shown in 
Table S1.
Reverse transcriptase-quantitative PCR (RT-qPCR) and western blotting
Total RNA from spleens or thymus or other organs of 5-wk-old Syrian hamsters was 
extracted using the TRIzol Reagent (Invitrogen, Carlsbad, CA, United States). First 
strand cDNA was synthesized from 1 μg of total RNA using PrimeScript RT Master 
Mix (Takara, Kyoto, Japan). SYBR-green based-qPCR reactions were performed in a 
StepOnePlus system (Applied Biosystems, Republic of Singapore) thermal cycler. 
Quantitative PCR reactions were carried out in triplicate, and the specific primers of 
different immune cell markers were previously described[13]. The mRNA expression 
was quantitated using the 2-(ΔCt sample–ΔCt control) method. Western blot analyses 
were performed as previously described[13]. Whole cell protein was isolated from 
spleens of 5-wk-old Syrian hamsters. Western blotting was performed for detection of 
the IL2RG protein (A-10 antibody, sc-271060, Santa Cruz Biotechnology, Dallas, TX, 
United States) while glyceraldehyde 3-phosphate dehydrogenase (60004-1-Ig, 
Proteintech, Rosemont, IL, United States) expression was used as a loading control.
Infection of hamsters with Ad5 and determination of anti-Ad5 neutralizing antibody 
(Nab) titers in the serum
The IL2RG homozygous Syrian hamsters and wild type (WT) control hamsters were 
anesthetized with 1.2% working solution avertin (45 mg/kg) and injected with 1 × 1010 
plaque forming units /kg of Ad5 by intramuscular injection. Day 14 after prime 
immunization, the hamsters were boosted using the same dose and route, and the 
hamsters were sacrificed on day 17. The Nab titer of the samples was determined as 
described previously[20]. In brief, serum samples were collected and incubated for 30 
min at 56°C to inactivate complement. Ad5 was incubated with serially diluted serum 
samples, and then then the mix (virus-serum) was added to A549 cells and incubated 
at 37°C. After 10 d, inhibition of cytopathic effects was measured. Nab titer in serum 
was determined as described previously[14].
Histopathological analysis
Tissues of the Syrian hamsters and immune-deficient mice were harvested, visually 
inspected, fixed in 10% neutral buffered formalin, and embedded in paraffin. The 
embedded tissues were stained with hematoxylin and eosin and Masson’s trichrome. 
Immunohistochemistry (IHC) analysis was conducted as described previously[16]. IHC 
of vimentin and smooth muscle actin (SMA) was performed using paraffin section of 
the tumors with a primary antibody against vimentin (ZM-0260, ZSGB-BIO, Beijing, 
China) and SMA antibody (ZM-0003, ZSGB-BIO). The histopathological results were 
evaluated by two independent pathologists.
Flow cytometry
Five-week-old hamsters were sacrificed, and single cells from the thymus and spleen 
were prepared for flow cytometric analyses. To obtain single-cell suspensions, tissues 
were cut to small pieces with scissors and passed through a 70-μm cell strainer (BD 
Biosciences, Franklin Lakes, NJ, United States) by pressing with plunger. The red 
blood cells were eliminated by using red blood cell lysis buffer. The prepared cells 
were stained with a 1:400 dilution of fluorescein isothiocyanate conjugated anti-mouse 
major histocompatibility complex (MHC) class II (I-Ek; clone 14-4-4S), a 1:300 dilution 
of antigen presenting cell conjugated anti-mouse CD4 (clone GK1.5) (all from E-
Bioscience, San Diego, CA, United States), a 1:100 dilution of anti-CD3 (clone 4F11 
developed by us[14]) was followed by incubation with a 1:50 dilution of a goat anti-
mouse secondary antibody (ZF-0312, ZSGB-BIO). The samples were analyzed on a BD 
Accuri C6 (BD Biosciences). The data were acquired using Accuri CFlow software (BD 
Biosciences) on the LSR II and analyzed using the FlowJo VX software.
Tumor cell xenotransplantation
Subcutaneous injections of 5 × 106 MIA-PaCa2 cells or other cells in the right upper 
flank were performed on 5-wk-old male ZZU001 Syrian hamsters (n = 14) and same 
age-matched B-NDG mice (n = 14). Tumor size was measured using calipers twice 
weekly until tumors reached 2000 mm3 (for B-NDG mice) or 3500 mm3 (for ZZU001 
Syrian hamster) or tumor ulceration occurred. Tumor volumes (V) were calculated 
using the formula V = (length × width2 × π)/6). Comparisons were analyzed by 
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Student’s t-test. All data were expressed as the mean ± standard deviation.
Orthotopic tumor model establishment
ZZU001 hamsters (n = 5) and B-NDG mice (n = 5) were anesthetized with 1.2% 
working solution avertin (45 mg/kg). Animals were placed in the dorsal decubitus 
position, and left subcostal incision was made. The pancreas was carefully exposed. 
MIA-PaCa2 cells (1 × 106) were suspended in matrigel (Corning, Bedford, MA, United 
States) (final volume: 50 μL). The cell suspension was orthotopically injected into the 
tail of the pancreas with a 29-gauge needle. The pancreas was returned to the 
peritoneal cavity, and the abdominal wall was closed in two layers with 3-0 nylon 
sutures (Huato, Suzhou, China). The animals were monitored daily for their general 
condition and sacrificed by CO2 10 wk after the orthotopic cell injection. Animals had 
to be killed earlier if one of the following criteria occurred: Formation of ascites with 
visible abdominal distension; jaundice, cachexia, or both associated with a significant 
clinical deterioration of the animal.
Statistical analysis
Statistical analyses were conducted using a Student's t-test for the comparison between 
groups. Results were considered significant at P < 0.05. The results were analyzed with 
GraphPad software (La Jolla, CA, United States).
RESULTS
Generation of X-SCID Syrian hamsters by CRISPR/Cas9
To produce IL2RG knock-out (KO) Syrian hamster, the CRISPR/Cas9 system with a 
single guide RNA designed to target the first exon of the hamster IL2RG gene 
(Figure 1A) was employed as described previously[18]. The validated sgRNA and Cas9 
mRNA were delivered into Syrian hamster zygotes by cytoplasmic injection. 
Cytoplasmic injected fertilized eggs were then transferred to pseudopregnant female 
hamsters (Table S2). Screening of eight newborn pups revealed that three (37.5%) 
carried targeted mutations. One had a 10 bp deletion that resulted in a reading 
frameshift in the IL2RG gene, leading to a premature stop codon (at 16th amino acid, 
Figure 1B and C). We established a viable breeding colony from the F0 founder 
carrying this indel. Because IL2RG is located on the X chromosome, the term of 
“homozygous KO” used herein refers to either female with both of the X chromosome 
alleles targeted or males with its single X chromosome targeted. The homozygous 
IL2RG KO hamsters were named ZZU001. As shown in Figure 1D, ZZU001 Syrian 
hamsters with homozygous 10 bp deletion of IL2RG had very little mRNA expression 
of IL2RG compared to wild type hamsters in thymus, as revealed by RT-qPCR, and no 
IL2RG protein expression in ZZU001 spleen was detectable by Western blotting 
(Figure 1E). In order to determine whether the IL2RG-specific sgRNA only induced 
mutations in the IL2RG gene but not in any other genomic loci, we identified six 
potential off-target sites using Benchling software (Table S3). Off-target analysis 
showed that no off-target events occurred in the 10 bp deletion of IL2RG founder (
Figure S1), indicating that the sgRNA used in this study is specific, and all features of 
ZZU001 are due to defects of the IL2RG gene and no other genetic changes.
Abnormal lymphoid cell development and impaired immune function in ZZU001 
Syrian hamsters
Gross necropsy and microscopic analyses of ZZU001 Syrian hamsters revealed 
impaired lymphoid development. The thymuses and spleens were examined at 5 wk 
of age in WT, heterozygous IL2RG KO, and homozygous IL2RG KO hamsters. The 
thymus of homozygous IL2RG KO hamsters was extremely hypoplastic and 
significantly reduced in size (Figure 2A), and consisted of an epithelial rudiment 
without any lymphocytes compared to WT (Figure 3A and B). The spleen of 
homozygous IL2RG KO hamsters was moderately decreased in size, as seen in 
Figure 2A. It was also much thinner and more loosely packed than those of 
heterozygous KO and WT hamsters, while the white pulp was almost completely 
devoid of lymphocytes compared to WT (Figure 3C and D). The thymus/body and 
spleen/body weight ratios in homozygous KO Syrian hamsters were lower than those 
in heterozygous KO and WT (Figure 2B). ZZU001 hamsters had no noticeable lymph 
nodes compared to WT hamsters (Figure 2C). In addition, IL2RG KO Syrian hamsters 
can survive over 72 wk (1.5 years), with a median survival time that exceeds 89 wk (
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Figure 1  Interleukin 2 receptor subunit gamma knockout Syrian hamsters (ZZU001) generated by CRISPR/Cas9. A: Schematic representation 
of the Syrian hamster interleukin 2 receptor subunit gamma (IL2RG) gene. The single-guide RNA target sequence is shown in green with the protospacer adjacent 
motif shown in red; B: Polymerase chain reaction product sequencing confirming the founder is shown. “Stat” refers to the mutant site; C: Sequencing assay for 
single-guide RNA/Cas9-IL2RG-induced mutation in the target region in Syrian hamsters. Multiple deletions are depicted by dashes; D: Quantitative real-time 
polymerase chain reaction analysis of IL2RG mRNA expression in the thymus of wild type and ZZU001 Syrian hamsters. bP < 0.01. n = 3. Glyceraldehyde 3-
phosphate dehydrogenase mRNA expression was used as an internal control; E: Western blotting assay to compare the expression of IL2RG protein in wild type and 
ZZU001 Syrian hamsters. Glyceraldehyde 3-phosphate dehydrogenase was used as a loading control. KO: Knock-out; sgRNA: Single-guide ribonucleic acid; WT: 
Wild type.
Figure S2).
RT-qPCR analysis of splenocytes of ZZU001 Syrian hamsters demonstrated that the 
expression of T lymphocyte-specific genes (CD3γ and CD4), B lymphocyte-specific 
genes [CD22 and FCMR (immunoglobulin M receptor)], and natural killer cell-specific 
genes (CD94 and Klrg1) were significantly lower than those in WT hamsters 
(Figure 3E). Immune cell marker gene expression was also examined in the thymus 
and bone marrow (Figure S3), showing a similar pattern as in the spleen (Figure 3E). In 
order to confirm further the deficiency of immune cells in IL2RG KO hamsters, flow 
cytometry analysis of immune molecules in monocytes isolated from thymus and 
spleen were performed. As shown in Figure S4, there was a clear decrease of the 
lymphocytes in ZZU001 Syrian hamsters; CD3+ or CD4+ positive T cells were almost 
absent from the ZZU001 hamster thymus and spleen. MHC class II positive cells were 
markedly decreased in ZZU001 Syrian hamster spleen (Figure S4B). There were no 
MHC class II expressing cells in the thymus. Consistent with the histology, the number 
of splenocytes and thymocytes was dramatically reduced in ZZU001 Syrian hamster 
compared with WT hamsters. Analysis of B cell function demonstrated that ZZU001 
Syrian hamsters could not produce neutralizing antibodies against Ad5 (Figure 3F) 
after infection with Ad5. Based on these findings, it is evident that ZZU001 hamsters 
have a severe immune deficiency in T cell, B cell, and possibly natural killer cells.
Subcutaneous xenotransplantation of human PC cells
Immune-deficient mice can accept transplanted tissues from humans. Having made 
severely immune-deficient ZZU001 Syrian hamsters, subcutaneous tumors of the 
human PC cell line MIA-PaCa-2 were established in ZZU001 hamsters and immune-
deficient B-NDG mice. It was found that xenografts tumors of the human PC cell line 
MIA-PaCa-2 developed well in both ZZU001 Syrian hamsters and B-NDG mice 
(Figure 4A). Consistent with previous reports, no distant metastasis in immune-
deficient mice was observed (Table 1, Figure 4B and C). In contrast, all ZZU001 
hamsters bearing subcutaneous tumors developed lung metastasis (occurring as early 
as 29 d after injection of the human PC cell line MIA-PaCa-2), coupled with metastasis 
in kidneys (40%) and adrenal glands (20%) (Table 1 and Figure 4B). Subcutaneous 
xenograft tumors from four other human PC cell lines, including Panc-1, SUIT-2, 
Patu8988T, and Capan-1, were established, and the tumor growth and remote organ 
metastasis were examined. As shown in Table 2, all four additional PC cell lines 
developed remote metastasis in lung, liver, and kidney although the remote metastatic 
frequency and sites varied between different PC cell lines.
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Table 2 Sites and frequency [n/n (%)] of distant metastasis of four different human pancreatic cancer cell lines
Panc-1 (SC) SUIT-2 (SC) Patu8988T (SC) Capan-1 (SC)
ZZU001 ZZU001 ZZU001 ZZU001
Distant metastasis
Liver - 1/3 (33) 3/5 (60) -
Lung 5/5 (100) 3/3 (100) - 5/5 (100)
Retroperitoneum - - - -
Mesentery - - - -
Diaphragm - - - -
Spleen - - - -
Stomach - - - -
Kidney - 1/3 (33) 1/5 (20) -
Adrenal gland - - - -
SC: Subcutaneous.
Orthotopic transplantation of human PC cells
Orthotopic transplantation models can mimic the biological behavior of the primary 
tumor more closely compared with subcutaneous transplantation models, although 
orthotopic xenotransplantation procedures are technically difficult to perform for PC, 
with strong potential for complications. In order to assess the potential value of a PC 
orthotopic model in ZZU001 hamsters, MIA-PaCa-2 cells were injected into pancreas 
of ZZU001 hamsters and B-NDG mice. Tumor formation rate was 100% (5/5) in the 
ZZU001 Syrian hamsters that received orthotopic transplantation of Mia-PaCa2 cells 
(Table 1), and hamsters developed metastasis at multiple-sites after orthotopic 
implantation, including the liver (100%), lung (100%), retroperitoneum (100%), 
mesentery (100%), diaphragm (40%), stomach (20%), kidney (100%), and adrenal gland 
(40%). In comparison, no lung metastasis was detected in the B-NDG mouse 
orthotopic model, and the frequency of metastasis to other organs was lower (Table 1). 
The histopathological features of cancer cells in the metastatic nodules presented 
similar morphological changes as those found in the primary tumors of pancreas, 
showing epithelial cell morphology. Tumor cells are strikingly heterogeneous within 
tumors and presented solid growth with nuclear polymorphism and abnormal mitoses 
while the desmoplastic stromal reaction is less developed in the most of metastatic 
tumors (Figure 5). Furthermore, ZZU001 Syrian hamster orthotopic models presented 
similar clinical and pathological features as observed in human patients, such as local 
infiltration of cancer cells and signs of tumor burden, including ascites, jaundice, ileus, 
and cachexia (Table 1).
Interaction of PC cells and stroma in xenograft tumors of PC
In order to dissect the possible mechanisms for metastasis of human PC in ZZU001 
hamsters, we investigated the alteration of stroma and tumor cells within the 
xenograft tumors derived from ZZU001 hamsters and B-NDG mice through 
biochemistry and IHC staining. Of note, desmoplastic reactions that consist of 
extracellular matrix proteins, including collagen and fibronectin (Figure 4D) and active 
fibroblasts [SMA-positive staining (Figure 4D)] were readily observed in the stroma of 
ZZU001 hamster xenograft tumors but not in the xenograft tumors derived from B-
NDG mice. Most interestingly, the tumor cells growing in ZZU001 hamsters displayed 
strong vimentin positive staining, indicative of epithelial to mesenchymal transition 
(EMT) (Figure 4D), whereas no obviously vimentin-positive tumor cells were observed 
in B-NDG mice xenograft tumors (Figure 4D). These observations suggest human PC 
cells could communicate with host cells of ZZU001 hamsters, which results in the 
improved engraftments and development of human tumor cells in ZZU001 Syrian 
hamsters. Thus, the ZZU001 hamster bearing PC model can recapitulate more key 
features of human PC, including metastasis and stromal reaction, compared to severe 
immune-deficient mice models.
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Figure 2  ZZU001 Syrian hamsters demonstrate abnormal lymphoid cell development and impaired immune function. A: The thymus and 
spleen of interleukin 2 receptor subunit gamma (IL2RG) knock-out (KO) hamsters were both evidently smaller than those of age-matched interleukin 2 receptor 
subunit gamma +/- and wild type (WT) hamsters; B: Comparison of spleen-to-body weight ratio. Each value represents the mean ± standard deviation (n = 3/group), 
Student’s t-test. bP < 0.01; and C: Dye labeling of Syrian hamster lymph nodes (LNs) and lymphatic vessels. Efferent lymphatic vessel (orange arrowhead). Axillary 
LN, Inguinal LN, and Renal LN (orange arrow) are LNs.
DISCUSSION
Implantation of human PC cells subcutaneously into immune-deficient mice has been 
widely used for the generation of in vivo human PC models, largely due to their 
comparatively low cost, ease and speed of establishment, and predictable tumor 
growth. However, these models do not faithfully recapitulate the features of human 
PC, in particular, as they fail to model the multiple-sites of metastasis observed during 
disease progression[5-7]. In the current study, we created an IL2RG KO immune-
deficient Syrian hamster (ZZU001) and demonstrated that an array of human PC cell 
lines, when subcutaneously transplanted, can result in multiple-sites of metastasis, 
including the lung, liver, kidney, and adrenal glands, although the metastasis 
frequency in liver is still low compared to observed levels in human patients. In 
striking contrast, no metastasis from any of these cell lines was observed in severe 
immune-deficient B-NDG mice. Therefore, the ZZU001 Syrian hamster model 
provides a novel animal model to recapitulate more accurately metastasis of human 
PC.
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Figure 3  ZZU001 Syrian hamsters demonstrate immune despair cellular abnormalities in lymphoid development. A and C: Representative 
histology of the wild type (WT) thymus and spleen. Bars = 100 µm; Representative histology of ZZU001 Syrian hamsters thymus B and spleen D and E: The 
expression of the indicated lymphocyte-specific genes in spleen homogenates was determined by reverse transcriptase quantitative polymerase chain reaction using 
the 2^ (-ΔΔCt) method. aP < 0.05. n = 3; F: Development of neutralizing antibodies against AdV-5. n = 3. aP < 0.05.
Pancreatic metastases can arise in any organ site but are mostly detected in 
abdominal sites. The liver is the most common organ in which metastasis is detected, 
followed by the peritoneum, lung and pleura, bones, and adrenal glands[21]. The 
comparison of MIA-PaCa-2 orthotopic models in B-NDG and ZZU001 (Table 1) 
demonstrates that the ZZU001 orthotopic tumor model presents a more accurate 
representation of human PC than the mouse models, particularly with regards to 
distant metastasis and local infiltration of cancer cells. Interestingly, ZZU001 xenograft 
models show a high frequency of kidney metastasis (40% in the subcutaneous model 
and 100% in the orthotopic model), although kidney metastasis of PC in humans has 
not been extensively reported[22]. This warrants further investigation.
PC progression is complemented by a fibrotic stromal (desmoplastic) reaction 
characterized by extensive deposition of extracellular matrix components, recruitment 
and activation of cancer-associated fibroblasts, decreased vasculature patency, and 
altered immune-surveillance[23]. Stromal remodeling leads to altered interactions 
between tumor cells and stromal compartments, which can promote tumor 
progression[24]. Presence of a robust, reactive, and desmoplastic stroma and the 
crosstalk between cancer cells and stromal cells are critical for PC progression and 
metastasis[25,26]. An ideal animal model of PC should reflect these important features, 
but xenografted tumors in mice rarely develop stromal reactions nor the EMT 
phenotype (Figure 4D). Strikingly, ZZU001 hamster xenograft tumors present a 
considerable amount of extracellular matrix reaction, as evidenced by diffusive strong 
Masson staining (Figure 4D) and activation of fibroblasts measured by expression of 
SMA (Figure 4D). The activated fibroblast may be a key factor affecting distant 
metastasis in ZZU001 hamster model as cancer-associated fibroblasts promote tumor 
growth and metastasis in a variety of ways[27]. Importantly, some tumor cells in 
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Figure 4  Xenotransplantation of human pancreatic cancer cells into ZZU001 Syrian hamsters recapitulates human pancreatic cancer 
metastasis. A: Growth curve of human MIA-PaCa-2 pancreatic cancer cells in ZZU01 Syrian hamsters and B-NDG mice. MIAPaCa-2 cells were subcutaneously 
inoculated into the flank of ZUU001 and B-NDG mice (n = 5/group). Tumors were measured twice weekly and the tumor volume estimated. Mean tumor size ± 
standard error of the mean is shown. ns: no significance; B: A representative hematoxylin and eosin (HE) stained section of a kidney and adrenal gland with 
metastatic tumor at the end of the experiment in ZZU001 hamsters (56 d) and B-NDG mice (42 d); C: Representative HE staining of a lung metastasis at 22 d, 29 d, 
36 d after the injection of MIA-PaCa-2 cells in ZZU001 hamsters and B-NDG mice; D: Representative HE, Masson, smooth muscle actin (SMA) and vimentin staining 
of a subcutaneous tumor at 42 d after the injection of the MIA-PaCa-2 cells in ZZU001 hamsters and B-NDG mice. Scale bars = 100 µm.
Figure 5  Metastasis in different organs reflects the histology of the primary tumor in ZZZU001 orthotopic xenograft tumor models. The 
primary tumors were established by injection of 1 × 106 of MIA-PaCa-2 cells into the pancreatic tail. The representative tumor in the pancreas, liver, lung, kidney, 
diaphragm, stomach, adrenal gland, and peritoneum of ZZU001 Syrian hamsters are shown. Inset square shows tumor cells at a magnification 400 ×. Scale bars = 
500 µm.
ZZU001 hamster xenograft tumor over-express vimentin, whereas no vimentin 
positive tumor cells were observed in mouse xenograft tumor. These observations 
suggest that the EMT of cancer cells in the ZZU001 hamster may be influenced by the 
stroma, which is highly associated with PC metastasis. The ZZU001 Syrian hamsters 
described in this study can be a valuable animal model for better understanding of the 
molecular mechanism of tumorigenesis, in particular for the metastasis of PC and 
testing novel therapeutics for this most aggressive disease.
ARTICLE HIGHLIGHTS
Research background
Pancreatic cancer (PC) is an extremely aggressive cancer with a poor prognosis. 
Multiple sites of metastasis from PC remain a significant hurdle in treating this 
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disease. Reliable animal models that can mimic the clinical features of the disease are 
needed to study disease progression and develop effective therapies. Xenograft cancer 
cell transplantation animal models are cost-effective and easily established methods by 
which to assess tumor progression, metastasis, and pre-clinical efficacy of cancer 
drugs. However, current xenograft tumor models of human PC in immune-deficient 
mice rarely develop metastasis. The development of a model that can reflect more 
accurately human PC progression is therefore required.
Research motivation
Syrian hamsters (Mesocricetus auratus) have advantages as models for various diseases 
due to the high similarities in anatomy, physiology, and pathology between Syrian 
hamsters and humans. The Syrian hamster is the only rodent species that develop PC 
in an almost identical manner to the respective human disease regarding such features 
as clinical symptoms, tumor morphology, tumor biology, metabolic abnormality, and 
molecular genetic alterations. We reasoned that the immune-deficient Syrian hamster 
might be a better animal species for establishing xenograft models of human PC and 
more faithfully recapitulate the features of PC, in particular the multiple sites of 
metastasis seen during progression of human PC.
Research objectives
This study aimed to create an immune-deficient Syrian hamster by knockout of 
interleukin 2 (IL-2) receptor subunit gamma (IL2RG), characterize the phenotypes of 
IL-2RG knockout (KO) Syrian hamsters, and evaluate whether this animal can present 
the distinguishing features of human PC.
Research methods
CRISPR/Cas9-mediated genetic editing and cytoplasmic injection into hamster 
zygotes were employed to create an IL2RG KO Syrian hamster. The phenotypes and 
immune functions of the IL2RG KO Syrian hamster were characterized. A panel of 
human PC cell lines were subcutaneously or orthotopically transplanted into IL2RG 
KO Syrian hamsters or immune-deficient mice. The tumor growth, local invasion of 
the tumor cells, and remote organ metastasis were compared over time. The 
histopathology of tumor xenografts, the molecular alterations of tumor cells, and the 
stroma within the xenograft tumors were investigated by hematoxylin and eosin and 
immunohistochemistry staining.
Research results
A new immune-deficient Syrian hamster with IL2RG gene knockout was created and 
named ZZU001. We demonstrated that ZZU001 Syrian hamsters have a lymphoid 
compartment that is greatly reduced in size and diversity and are impaired in their 
immune function. The comparison studies on xenografting tumors in ZZU001 and 
severely immune-deficient mice demonstrated that ZZU001 Syrian hamsters engrafted 
with human tumor cells are a promising animal model, which can recapitulate most of 
the features of human PC, in particular, the multiple-sites of metastasis. PC tissues 
derived from ZZU001 hamsters also displayed other key features of human PC, such 
as desmoplastic reactions in the stroma and epithelial to mesenchymal transition 
phenotype, whereas PC tissues derived from immune-deficient mice did not present 
such features.
Research conclusions
This work demonstrates that ZZU001 Syrian hamster can be an extremely valuable 
animal model for better understanding the molecular mechanisms of tumorigenesis, in 
particular the metastasis of human PC, and maybe more appropriate in comparison to 
xenograft mouse models for robust testing of the anti-tumor potential of novel 
therapeutics.
Research perspectives
Current findings provide a promising xenotransplantation animal model for human 
PC research. Its wider application requires further evaluation, but the strong 
similarities between progression of human and Syrian hamster PC may suggest a 
similarly useful application of this model for more accurately modeling the 
progression of other human tumors. The model characterized in this study may also 
provide a useful platform for identification of novel molecules and pathways that 
control the metastasis of human PC.
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